Results 141 to 150 of about 13,423 (179)

Conceptualizing the relationship between synthetic cannabinoid use and neuroleptic malignant syndrome. [PDF]

Bipolar Disord
Zhang V, Wirtz AJ, Dhingra A, Zahid A, Hussain N.   +4 more
europepmc   +1 more source

Tail-less precursors in synthetic cannabinoid production: investigating a clandestine laboratory, seized samples, and CB₁ activity. [PDF]

Arch Toxicol
Monti MC, Rautio T, Deventer MH, Schläpfer M, Tveit J, Krotulski AJ, Marland V, Reid R, Daeid NN, McKenzie C, Stove CP, Green H, Norman C.   +12 more
europepmc   +1 more source

Structure-metabolism relationships of 4-pentenyl synthetic cannabinoid receptor agonists using in vitro human hepatocyte incubations and high-resolution mass spectrometry. [PDF]

Arch Toxicol
Baginski SR, Lindbom K, Valencia Crespo B, Bessa G, Rautio T, Wu X, Dahlén J, Nisbet LA, McKenzie C, Gréen H.   +9 more
europepmc   +1 more source

In vivo assessment of the nephrotoxic effects of the synthetic cannabinoid AB-FUBINACA. [PDF]

Forensic Toxicol
Alzu'bi A, Abu-El-Rub E, Al-Trad B, Alzoubi H, Abu-El-Rub H, Albals D, Abdelhady GT, Bader NS, Almazari R, Al-Zoubi RM.   +9 more
europepmc   +1 more source

The rise of so-called adolescent "zombie" behavior: a spotlight on synthetic cannabinoid abuse. [PDF]

Braz J Psychiatry
Mendonça-Ferreira P, Bombana H, Castaldelli-Maia JM.   +2 more
europepmc   +1 more source

Reelin Deficiency and Synaptic Impairment in the Adolescent Prefrontal Cortex Following Initial Synthetic Cannabinoid Exposure. [PDF]

Biol Psychiatry Glob Open Sci
Silva-Hurtado TJ, Giua G, Lassalle O, Makrini-Maleville L, Strauss B, Wager-Miller J, Freyermuth JM, Mackie K, Valjent E, Manzoni OJJ, Chavis P.   +10 more
europepmc   +1 more source

Identification and Investigation of the Intrinsic Receptor Activation Potential and Metabolization of the New Oxo-Pyridyl Synthetic Cannabinoid Receptor Agonist CH-FUBBMPDORA. [PDF]

Drug Test Anal
Deventer MH, Emanuele MC, Stang BN, Van Uytfanghe K, Masson J, Bouvot X, Lamoureux C, Proposito A, Reniero F, Holland MV, Krotulski AJ, Mannina L, Stove CP, Guillou C.   +13 more
europepmc   +1 more source

Synthetic cannabinoid receptor agonists containing silicon: exploring the metabolic pathways of ADMB- and Cumyl-3TMS-PrINACA in human urine specimens and post mortem material compared to in vitro and in silico data. [PDF]

Arch Toxicol
Zschiesche A, Carlier J, Pietsch J, Scheu M, Seibt J, Busardò FP, Auwärter V, Huppertz LM.   +7 more
europepmc   +1 more source

Activity-based detection of synthetic cannabinoid receptor agonists in plant materials. [PDF]

Harm Reduct J
Timmerman A, Balcaen M, Coopman V, Degreef M, Pottie E, Stove CP.   +5 more
europepmc   +1 more source

Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice. [PDF]

J Alzheimers Dis Rep
Ott FW, Sichler ME, Bouter C, Enayati M, Wiltfang J, Bayer TA, Beindorff N, Löw MJ, Bouter Y.   +8 more
europepmc   +1 more source